DOJ, HHS open six-month FCA self-disclosure pilot for health care groups
Health care organizations that voluntarily disclose potential civil False Claims Act violations may qualify for reduced damages and favorable settlement terms under a new DOJ-HHS pilot open until April 22, 2027.
The DOJ and HHS have launched a six-month False Claims Act Self-Disclosure Pilot Program, reported to remain open through April 22, 2027, under which eligible health care organizations that voluntarily disclose potential civil FCA violations may receive reduced damages and favorable settlement terms. Program specifics beyond eligibility and the availability of mitigation are not set out in the available reporting, so the damages-reduction mechanics, any monetary cap, and conditions such as government approval or credit for cooperation remain unconfirmed.
For sophisticated counsel the significance is structural rather than numerical: it creates a time-limited, agency-sanctioned channel to address FCA exposure before a qui tam relator or an investigation escalates, and it puts a DOJ- and HHS-endorsed framework alongside private settlement negotiations with the Office of Inspector General. Health care clients should treat the window as a decision deadline rather than an option, running a disclosure-readiness assessment in parallel with any remediation or investigation strategy, and verifying the eligible-organization criteria and required process as implementing materials and sub-regulatory guidance appear.
Watch for the first pilot participants and the terms of the first public resolutions, and for any extension or conversion of the pilot into a standing program.